Invasive Lobular Carcinoma
Invasive Lobular Carcinoma (ILC) is a breast cancer that begins in the milk-producing lobules and can infiltrate surrounding breast tissue.
Patients may notice subtle thickening, changes in breast shape, or a lump. Early detection through imaging and biopsy is crucial, and treatment may involve surgery, chemotherapy, hormonal therapy, or radiation.
Causes and Risk Factors of Invasive Lobular Carcinoma
ILC arises from abnormal cell growth in the lobules of the breast.
- Hormonal influence: Estrogen exposure can increase risk.
- Genetic factors: BRCA mutations may predispose.
- Age and family history: Mostly affects women over 50 or with relatives with breast cancer.
Symptoms and Clinical Indicators
Symptoms may be subtle and easily overlooked.
- Palpable thickening or lump in the breast
- Change in breast shape or size: Subtle distortion may occur
- Nipple changes or discharge
- Skin dimpling or redness
Treatment Modalities for Invasive Lobular Carcinoma
Treatment depends on stage, tumor size, and hormone receptor status.
- Surgical intervention: Lumpectomy or mastectomy based on tumor extent.
- Chemotherapy and radiotherapy: Used according to stage and risk.
- Hormonal therapy for estrogen/progesterone receptor-positive tumors.
Why Choose Us for Invasive Lobular Carcinoma
CureU Healthcare provides multidisciplinary breast oncology care, modern imaging, precision surgery, and tailored post-operative management for best outcomes.
Conclusion
Invasive Lobular Carcinoma is treatable with early detection and comprehensive care. CureU Healthcare ensures expert surgical and medical oncology management for optimal patient outcomes.
